Business Context and Reporting Period
Company: DFB Healthcare Acquisitions Corp. (Registrant) and AdaptHealth Holdings LLC (Target Company).
Reporting Date: July 12, 2019 (Event Date: July 8, 2019).
Event: Entry into a Material Definitive Agreement (Agreement and Plan of Merger) to combine DFB Healthcare with AdaptHealth Holdings LLC. Upon consummation, DFB Healthcare will change its name to AdaptHealth Holding Corporation. The transaction will result in AdaptHealth becoming a partially owned subsidiary of DFB Healthcare in an "Up-C" structure.
Key Financial Metrics and Transaction Terms
Transaction Valuation: The aggregate merger closing consideration is based on $515,000,000.
Consideration Structure:
- Equity: DFB Healthcare will issue up to 51.5 million shares of common stock.
- Cash Option: Holders may elect to receive cash up to an aggregate of $50.0 million, reducing the equity issuance accordingly.
- Contingent Consideration: Up to 3,000,000 additional units/shares may be issued based on future stock price milestones ($15.00 in Dec 2020, $18.00 in Dec 2021, $22.00 in Dec 2022).
Private Placement (PIPE): Deerfield Private Design Fund IV, L.P. agreed to purchase between 5,000,000 and 10,000,000 shares at $10.00 per share.
Liquidity Condition: Closing requires DFB Healthcare to hold at least $225,000,000 in cash (including Trust Account and PIPE proceeds) after redemptions.
Debt Cap: The Company must not have indebtedness exceeding $470,000,000 plus specific lease obligations and acquisition-related debt at closing.
Financial Statements: This 8-K filing does not provide historical revenue, profit, cash flow, or margin data for AdaptHealth. Such data is expected to be included in the forthcoming Proxy Statement.
Material Changes and Transaction Mechanics
Corporate Structure: The transaction involves a series of mergers (Blocker Mergers) followed by the main Merger. The surviving entity will be organized as a limited liability company (the "Surviving Company") with DFB Healthcare as the sole manager.
Stock Classes: The post-transaction entity will have two classes of stock: Class A (voting and economic rights) and Class B (voting rights only, held by former AdaptHealth unitholders).
Management Changes: DFB Healthcare will become the initial sole manager. The board will include directors designated by BlueMountain, Deerfield, and an independent director.
Lock-up Agreements: Certain members are restricted from selling securities for periods ranging from three to nine months post-closing.
Guidance, Risks, and Contingencies
Conditions to Closing: The transaction is subject to stockholder approval, regulatory approvals (including HSR Act), and the delivery of audited financial statements by September 30, 2019.
Termination Rights: The agreement may be terminated if the merger is not consummated by January 31, 2020, or if required approvals are not obtained.
Risks and Uncertainties:
- Failure to obtain stockholder or regulatory approval.
- Significant redemption requests by DFB Healthcare stockholders reducing available cash below the $225 million threshold.
- Integration risks and failure to realize anticipated benefits.
- Forward-looking statements regarding future performance are subject to standard risks and uncertainties.
Outlook: Management anticipates the transaction will close subject to the satisfaction of conditions, with a proxy statement to be filed to solicit stockholder approval.
Investor Verification Checklist
- Proxy Statement: Review the definitive proxy statement for AdaptHealth's audited financial statements, which are not included in this 8-K.
- Redemption Risk: Monitor the level of redemption requests by DFB Healthcare stockholders to ensure the $225 million cash condition is met.
- Debt Levels: Verify the Company's indebtedness at closing does not exceed the $470 million cap plus permitted exceptions.
- Regulatory Approval: Confirm receipt of all necessary governmental and antitrust approvals.
- PIPE Commitment: Confirm the final number of shares purchased by Deerfield (between 5M and 10M) and the total cash raised.